| 05/25/2010 |  | Current Trends in BioPharma Alliances | | PDF file (873k) |
| |
|
| 03/05/2010 | | Biotech Finance & Business Development | College of Management, Georgia Institute of Technology | PDF file (1,158k) |
| |
|
| 01/25/2010 | | Looking Back at 2009 - Trends in Licensing and Partnerships | BioPartnering North America | PDF file (327k) |
| |
|
| 01/19/2010 | | Current Practices in BioPharma Alliances | Trends in the Marketplace and Key Insights | PDF file (1,166k) |
| |
|
| 12/03/2009 | | Introduction to BioPharma Business Development | UCSC Extension | PDF file (744k) |
| |
|
| 10/01/2009 | | What Pharma is Really Looking For: A Review of the Recent Deal-Making at Pharma and Biotech | BioPartnering Europe 2009 | PDF file (1,029k) |
| | Come with us as we look behind the data at the latest trends in deal structuring and valuation. We will explore the deal-making of the last two years, provide insights into the current market for deals, and present methods for you to speed the business development process and maximize deal valuation.
Deloitte Recap LLC (formerly Recombinant Capital, Inc.), has been providing analysis and insights on partnering for over 20 years as a trusted advisor to the biotech industry. Deloitte Recap LLC has advised hundreds of biotech companies and assisted on more than $12 billion of announced new partnering deals.
|
| 08/18/2009 | | What is the impact of the current market on biopharma alliances? | Deloitte Recap LLC Webinar | PDF file (650k) |
| |
|
| 08/05/2008 | | The Yin and Yang of Biotech Business Development | Presentation at the Masachusettes Biotech Council | PDF file (284k) |
| | Financing and partnerships provide the fuel for corporate development. The role of the business development professional is to orchestrate these transactions in order to capture value and provide maximum upside. New financing facilities and more complex alliance models are expanding the abilities of BD to accomplish just that. Come here the latest trends affecting Biotech business development, see the data, and participate in discussions with your colleagues on how you can best succeed at implementing strategy in todays markets.
|